Physician profile
Ryan M Nunley
NPI 1164568887
$3,944,573.62
in general payments reported to CMS, 2019-2025
16 companies · $726K in 2025
The $726K reported for 2025 was more than what 98% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $625K · 2020: $502K · 2021: $346K · 2022: $417K · 2023: $592K · 2024: $737K · 2025: $726K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.4M · Consulting Fee: $601K · Travel and Lodging: $35K · Food and Beverage: $6,117 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,412,334.13 |
| Consulting Fee | $600,675.92 |
| Travel and Lodging | $34,808.26 |
| Food and Beverage | $6,116.60 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,346,770.21 | 2019-2025 | Attune, Velys, Actis |
| Depuy Synthes Products, INC. | $1,175,094.19 | 2019-2025 | Attune, Velys |
| Smith+Nephew, INC. | $896,979.93 | 2019-2025 | Navio, Real Intelligence |
| Ethicon INC. | $322,699.38 | 2019-2025 | Attune, Velys, Dermabond Prineo |
| Ethicon Endo-Surgery INC. | $65,835.00 | 2023-2024 | Stratafix, Dermabond Prineo, Monocryl |
| Microport Orthopedics INC | $57,475.68 | 2019-2022 | |
| Medtronic USA, INC. | $47,113.63 | 2019-2020 | |
| Ethicon US, LLC | $20,807.55 | 2020-2025 | Attune, Velys, Dermabond |
| Depuy Synthes Sales INC. | $5,319.00 | 2019-2025 | Attune, Actis, Velys |
| Heron Therapeutics, INC. | $3,122.02 | 2019 | |
| Medtronic, INC. | $2,490.00 | 2023 | Aquamantys(Tm) |
| Synthes Gmbh | $500.00 | 2024 | |
| Medacta USA, INC. | $141.41 | 2024 | |
| Exactech, INC. | $99.97 | 2021 | |
| Biocomposites INC | $93.02 | 2019-2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $32.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Nunley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.